News Releases

SAINT PAUL, Minn., Aug. 9, 2016 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD), a global medical technology company, today announced that Todd Austin, Chief Executive Officer and Wes Winnekins, Chief Financial Officer, will present at the 5^th Annual 2016 InvestMNt Conference on Wednesday, August 24, 2016 at 1:30 p.m. CT. The conference will be held at the University of St. Thomas in downtown Minneapolis, MN. The conference is sponsored by CFA Society of Minneapolis.

The presentation will be webcast live by MeetMax and can be accessed by registering at www.investMNt.org.   

The management of MGC Diagnostics will be available for one-on-one meetings at the conference on Wednesday, August 24, 2016. Investors interested in arranging a meeting should contact an InvestMNt representative. Conversely, you may also call Lytham Partners at (602) 889-9700.

A total of 80 companies from the Upper Midwest and elsewhere are participating in the conference, which is sponsored by the 1,300-member CFA Society and financially supported by more than 30 institutional investment firms and corporate sponsors.  For more information and to register, visit http://investmnt.org.   

About InvestMNt
Now in its 5th year, InvestMNt is a two-day conference developed by institutional investors at mutual funds, private money management firms, retirement plan sponsors and other wealth management entities. Last year's event featured C-level executives from 53 presenting companies, plus more than 200 one-on-one meetings with senior management. More than 400 people attended last year's event, which was conceived and implemented by the CFA Society of Minnesota.

About CFA Society of Minnesota
Founded in 1952, CFA Society Minnesota is one of the oldest chapters of prestigious CFA Institute, issuer of the Chartered Financial Analyst® Designation. CFA Society Minnesota is the 23rd largest society among the 145 member societies and affiliates worldwide. For more than 60 years we have endeavored to play a vital role within the Twin Cities investment community.

About MGC Diagnostics
MGC Diagnostics Corporation (NASDAQ: MGCD), is a global medical technology company dedicated to cardiorespiratory health solutions. The Company, through its Medical Graphics Corporation and Medisoft SA subsidiaries, develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provides solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and, in the United States, France and Belgium, primarily through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com.  

Contacts

SOURCE MGC Diagnostics Corporation